Physician profile
George Psaltis
NPI 1124355839
$537.42
in general payments reported to CMS, 2019-2025
10 companies · $98.98 in 2025
The $98.98 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $104 · 2021: $21.78 · 2022: $68.41 · 2023: $108 · 2024: $22.14 · 2025: $98.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130 · Debt Forgiveness: $98.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.11 |
| Debt Forgiveness | $98.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Darby Dental Supply, LLC | $98.98 | 2025 | |
| Dentsply Sirona INC | $76.40 | 2020-2023 | Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive, Mis |
| Tulsa Dental Products LLC | $75.90 | 2020 | |
| Henry Schein, INC. | $74.25 | 2019 | |
| Ultradent Products INC | $52.99 | 2022 | |
| Nobel Biocare USA | $43.01 | 2023 | Nobelactive |
| Carestream Dental, LLC | $42.72 | 2019-2021 | |
| Straumann USA LLC | $34.46 | 2019-2022 | |
| Geistlich Pharma, North America, INC. | $22.14 | 2024 | Geistlich Bio-Gide |
| Kulzer, LLC | $16.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Psaltis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.